Booker Stops Taking Pharma Money, Again Seeks Bipartisan Drug Pricing Action

/ July 6, 2017 at 6:19 PM
Sen. Cory Booker (D-NJ) recently announced he will no longer accept donations from pharma companies due to public criticism. Booker also argued that drug pricing is a bipartisan issue Congress could pursue to improve the U.S. health care system, and is a more useful pursuit than attempting to repeal and replace Obamacare. “[W]e have a crisis in this country with the expense of prescription drugs. What we should be doing is coming together as national leaders,” Booker told National Public...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.